Skip to main content

Advertisement

Table 3 Health care utilization during 61 weeks

From: Supervised neuromuscular exercise prior to hip and knee replacement: 12-month clinical effect and cost-utility analysis alongside a randomised controlled trial

  Intervention group (n = 84) Control group (n = 81)  
  Mean difference (95% CI)
Intervention
  Exercise sessions, mean (range) 13.1 (0–24) 0 13.1 (12.2 to 14.0)
Primary health care, visits
  General practice 18.2 (1.3) 19.5 (1.7) −1.36 (−5.46 to 2.74)
Physiotherapist 0.3 (0.1) 0.5 (0.2) −0.27 (−0.81 to 0.27)
Medical specialist 0.9 (0.2) 1.0 (0.2) −0.05 (−0.57 to 0.48)
Chiropractor 0 0.4 (0.03) −0.40 (−0.77 to −0.03)
Othera 2.0 (0.1) 2.2 (0.2) −0.28 (−0.72 to 0.16)
Subtotal 21.4 (1.3) 23.7 (1.7) −2.36 (−6.61 to 1.90)
Secondary health care, visits
  Outpatient 8.4 (0.9) 8.5 (1.0) −0.13 (−2.80 to 2.55)
Emergency 0.2 (0.1) 0.5 (0.1) −0.24 (−0.52 to 0.03)
Subtotal 8.6 (0.9) 9.0 (1.1) −0.37 (−3.16 to 2.43)
Secondary health care, inhospital days
  Orthopeadic 3.6 (0.4) 4.6 (1.1) −0.95 (−3.32 to 1.42)
Surgeryb 0.3 (0.1) 1.2 (0.7) −0.91 (−2.28 to 0.45)
Medicinec 0.7 (0.3) 0.8 (0.3) −0.12 (−0.92 to 0.68)
Oncologyd 0 0.4 (0.3) −0.37 (−0.95 to 0.22)
Other 0.3 (0.2) 0.3 (0.3) −0.01 (−0.72 to 0.70)
Subtotal 4.8 (0.7) 7.2 (1.8) −2.36 (−6.11 to 1.38)
  1. Variables are expressed as the mean (bootstrap SE) number of outpatient visits or in-hospital days per patient during the 61 week follow-up period and the mean difference (95% confidence interval) between groups
  2. aOther, includes visits at the dentistry, laboratory or foot care clinic
  3. bSurgery, gastrointestinal, urology, plastic, thoracic
  4. cMedicine, internal medicine, cardiology, medical gastroenterology, neurology, geriatrics, general practice
  5. dOther, includes inhospital stay at oftamology, odontology or physiotherapy units